Skip to Main Content

Twice a year, hopeful soccer fans are treated to the transfer window, a period in which teams can buy players from one another. It’s known widely as the sport’s “silly season” because it invites fans to dream of impossible signings and circulate flimsy rumors that Star Brazilian Striker X was spotted at the airport on his way to Woeful English City Y. Most of the time, no such thing happens.

On Wednesday, former Celgene shareholders experienced the biotech version of that magical thinking when investors on the Internet passed around blurry photos of what may or may not be FDA inspectors walking into what may or may not be a Celgene manufacturing plant.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


Comments are closed.